Recent studies have questioned treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections with vancomycin because of treatment failures, despite vancomycin MICs in the susceptible category (MIC ≤ 2 μg/ml) ([2][1], [3][2], [5][3], [6][4], [7][5]). Some of these studies have
No takes yet. Share an insight, caveat, or question.
Prakash et al. (2008) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: